ALLOGENEIC 0 10 0 10 B-treatment
TRANSPLANTATION 11 26 11 26 I-treatment

Any 0 3 27 30 O
significant 4 15 31 42 O
medical 16 23 43 50 B-chronic_disease
complications 24 37 51 64 I-chronic_disease
related 38 45 65 72 O
to 46 48 73 75 O
therapy 49 56 76 83 B-treatment
must 57 61 84 88 O
have 62 66 89 93 O
resolved 67 75 94 102 O

Aspartate 0 9 103 112 B-clinical_variable
aminotransferase 10 26 113 129 I-clinical_variable
( 27 28 130 131 I-clinical_variable
AST 28 31 131 134 I-clinical_variable
) 31 32 134 135 I-clinical_variable
and 33 36 136 139 O
alanine 37 44 140 147 B-clinical_variable
aminotransferase 45 61 148 164 I-clinical_variable
( 62 63 165 166 I-clinical_variable
ALT 63 66 166 169 I-clinical_variable
) 66 67 169 170 I-clinical_variable
< 68 69 171 172 O
3 70 71 173 174 B-upper_bound
x 72 73 175 176 I-upper_bound
upper 74 79 177 182 I-upper_bound
limit 80 85 183 188 I-upper_bound
of 86 88 189 191 I-upper_bound
normal 89 95 192 198 I-upper_bound
( 96 97 199 200 I-upper_bound
ULN 97 100 200 203 I-upper_bound
) 100 101 203 204 I-upper_bound
( 102 103 205 206 O
obtained 103 111 206 214 O
= 112 113 215 216 O
< 113 114 216 217 O
48 115 117 218 220 B-upper_bound
hours 118 123 221 226 I-upper_bound
prior 124 129 227 232 I-upper_bound
to 130 132 233 235 O
registration 133 145 236 248 O
) 145 146 248 249 O

Diagnostic 0 10 250 260 O
bone 11 15 261 265 O
marrow 16 22 266 272 O
and 23 26 273 276 O
peripheral 27 37 277 287 O
blood 38 43 288 293 O
specimens 44 53 294 303 O
must 54 58 304 308 O
be 59 61 309 311 O
submitted 62 71 312 321 O
for 72 75 322 325 O
immunophenotyping 76 93 326 343 O
and 94 97 344 347 O
selected 98 106 348 356 O
molecular 107 116 357 366 O
testing 117 124 367 374 O
, 124 125 374 375 O
and 126 129 376 379 O
the 130 133 380 383 O
establishment 134 147 384 397 O
of 148 150 398 400 O
BCR 151 154 401 404 O
/ 154 155 404 405 O
ABL 155 158 405 408 O
status 159 165 409 415 O
; 165 166 415 416 O
testing 167 174 417 424 O
will 175 179 425 429 O
be 180 182 430 432 O
performed 183 192 433 442 O
by 193 195 443 445 O
the 196 199 446 449 O
Eastern 200 207 450 457 B-clinical_variable
Cooperative 208 219 458 469 I-clinical_variable
Oncology 220 228 470 478 I-clinical_variable
Group 229 234 479 484 I-clinical_variable
( 235 236 485 486 I-clinical_variable
ECOG)-American 236 250 486 500 I-clinical_variable
College 251 258 501 508 I-treatment
of 259 261 509 511 I-treatment
Radiation 262 271 512 521 I-treatment
Imaging 272 279 522 529 I-treatment
Network 280 287 530 537 I-treatment
( 288 289 538 539 I-treatment
ACRIN 289 294 539 544 I-treatment
) 294 295 544 545 I-treatment
Leukemia 296 304 546 554 O
Translational 305 318 555 568 O
Research 319 327 569 577 O
Laboratory 328 338 578 588 O
( 339 340 589 590 O
LTRL 340 344 590 594 O
) 344 345 594 595 O
and 346 349 596 599 O
reported 350 358 600 608 O
to 359 361 609 611 O
the 362 365 612 615 O
institution 366 377 616 627 O

Direct 0 6 628 634 O
or 7 9 635 637 O
total 10 15 638 643 B-clinical_variable
bilirubin 16 25 644 653 I-clinical_variable
< 26 27 654 655 O
1.5 28 31 656 659 B-upper_bound
x 32 33 660 661 I-upper_bound
ULN 34 37 662 665 I-upper_bound
( 38 39 666 667 O
unless 39 45 667 673 O
related 46 53 674 681 O
to 54 56 682 684 O
Gilbert 57 64 685 692 B-chronic_disease
's 64 66 692 694 I-chronic_disease
or 67 69 695 697 I-chronic_disease
Meulengracht 70 82 698 710 I-chronic_disease
's 82 84 710 712 I-chronic_disease
syndrome 85 93 713 721 I-chronic_disease
) 93 94 721 722 O
; 94 95 722 723 O
the 96 99 724 727 O
values 100 106 728 734 O
must 107 111 735 739 O
be 112 114 740 742 O
obtained 115 123 743 751 O
within 124 130 752 758 O
48 131 133 759 761 B-upper_bound
hours 134 139 762 767 I-upper_bound
prior 140 145 768 773 I-upper_bound
to 146 148 774 776 O
randomization 149 162 777 790 O

ECOG 0 4 791 795 B-clinical_variable
performance 5 16 796 807 I-clinical_variable
score 17 22 808 813 I-clinical_variable
0 23 24 814 815 B-lower_bound
- 24 25 815 816 O
3 25 26 816 817 B-upper_bound

ECOG 0 4 818 822 B-clinical_variable
performance 5 16 823 834 I-clinical_variable
status 17 23 835 841 I-clinical_variable
0 24 25 842 843 B-lower_bound
- 25 26 843 844 O
2 26 27 844 845 B-upper_bound

Hydroxyurea 0 11 846 857 B-treatment
can 12 15 858 861 O
be 16 18 862 864 O
given 19 24 865 870 O
for 25 28 871 874 O
up 29 31 875 877 O
to 32 34 878 880 O
5 35 36 881 882 B-upper_bound
days 37 41 883 887 I-upper_bound
prior 42 47 888 893 I-upper_bound
to 48 50 894 896 O
initiation 51 61 897 907 O
of 62 64 908 910 O
protocol 65 73 911 919 O
therapy 74 81 920 927 B-treatment
for 82 85 928 931 O
control 86 93 932 939 O
of 94 96 940 942 O
leukocyte 97 106 943 952 O
count 107 112 953 958 O
and/or 113 119 959 965 O
other 120 125 966 971 O
symptoms 126 134 972 980 O
or 135 137 981 983 O
signs 138 143 984 989 O
; 143 144 989 990 O
corticosteroids 145 160 991 1006 B-treatment
can 161 164 1007 1010 O
be 165 167 1011 1013 O
given 168 173 1014 1019 O
after 174 179 1020 1025 O
pre 180 183 1026 1029 O
- 183 184 1029 1030 O
registration 184 196 1030 1042 O
to 197 199 1043 1045 O
the 200 203 1046 1049 O
protocol 204 212 1050 1058 O
and 213 216 1059 1062 O
submission 217 227 1063 1073 O
of 228 230 1074 1076 O
baseline 231 239 1077 1085 O
marrow 240 246 1086 1092 O
and 247 250 1093 1096 O
blood 251 256 1097 1102 O
samples 257 264 1103 1110 O
for 265 268 1111 1114 O
control 269 276 1115 1122 O
of 277 279 1123 1125 O
leukocyte 280 289 1126 1135 O
count 290 295 1136 1141 O
and/or 296 302 1142 1148 O
other 303 308 1149 1154 O
symptoms 309 317 1155 1163 O
or 318 320 1164 1166 O
signs 321 326 1167 1172 O
prior 327 332 1173 1178 O
to 333 335 1179 1181 O
initiation 336 346 1182 1192 O
of 347 349 1193 1195 O
protocol 350 358 1196 1204 O
therapy 359 366 1205 1212 O
if 367 369 1213 1215 O
needed 370 376 1216 1222 O
; 376 377 1222 1223 O
if 378 380 1224 1226 O
corticosteroids 381 396 1227 1242 O
are 397 400 1243 1246 O
given 401 406 1247 1252 O
prior 407 412 1253 1258 O
to 413 415 1259 1261 O
pre 416 419 1262 1265 O
- 419 420 1265 1266 O
registration 420 432 1266 1278 O

In 0 2 1279 1281 O
B 3 4 1282 1283 B-cancer
- 4 5 1283 1284 I-cancer
lineage 5 12 1284 1291 I-cancer
ALL 13 16 1292 1295 I-cancer
, 16 17 1295 1296 O
MRD 18 21 1297 1300 B-clinical_variable
levels 22 28 1301 1307 I-clinical_variable
in 29 31 1308 1310 O
peripheral 32 42 1311 1321 O
blood 43 48 1322 1327 O
or 49 51 1328 1330 O
from 52 56 1331 1335 O
a 57 58 1336 1337 O
dilute 59 65 1338 1344 O
marrow 66 72 1345 1351 O
aspiration 73 83 1352 1362 O
can 84 87 1363 1366 O
be 88 90 1367 1369 O
300 91 94 1370 1373 B-upper_bound
% 94 95 1373 1374 I-upper_bound
lower 96 101 1375 1380 O
, 101 102 1380 1381 O
on 103 105 1382 1384 O
average 106 113 1385 1392 O
, 113 114 1392 1393 O
than 115 119 1394 1398 O
those 120 125 1399 1404 O
in 126 128 1405 1407 O
bone 129 133 1408 1412 O
marrow 134 140 1413 1419 O
at 141 143 1420 1422 O
a 144 145 1423 1424 O
given 146 151 1425 1430 O
time 152 156 1431 1435 O
point 157 162 1436 1441 O
; 162 163 1441 1442 O
submitting 164 174 1443 1453 O
a 175 176 1454 1455 O
first 177 182 1456 1461 O
pull 183 187 1462 1466 O
from 188 192 1467 1471 O
a 193 194 1472 1473 O
separate 195 203 1474 1482 O
aspiration 204 214 1483 1493 O
site 215 219 1494 1498 O
will 220 224 1499 1503 O
ensure 225 231 1504 1510 O
that 232 236 1511 1515 O
MRD 237 240 1516 1519 O
determinations 241 255 1520 1534 O
used 256 260 1535 1539 O
in 261 263 1540 1542 O
randomization 264 277 1543 1556 O
and 278 281 1557 1560 O
trial 282 287 1561 1566 O
interpretation 288 302 1567 1581 O
are 303 306 1582 1585 O
accurate 307 315 1586 1594 O

It 0 2 1595 1597 O
is 3 5 1598 1600 O
recommended 6 17 1601 1612 O
to 18 20 1613 1615 O
utilize 21 28 1616 1623 O
a 29 30 1624 1625 O
regimen 31 38 1626 1633 O
of 39 41 1634 1636 O
the 42 45 1637 1640 O
integrase 46 55 1641 1650 B-treatment
inhibitor 56 65 1651 1660 I-treatment
, 65 66 1660 1661 O
dolutegravir 67 79 1662 1674 B-treatment
, 79 80 1674 1675 O
combined 81 89 1676 1684 O
with 90 94 1685 1689 O
either 95 101 1690 1696 O
disoproxil 102 112 1697 1707 B-treatment
fumarate 113 121 1708 1716 I-treatment
/ 121 122 1716 1717 O
emtricitabine 122 135 1717 1730 B-treatment
or 136 138 1731 1733 O
dolutegravir 139 151 1734 1746 O
combined 152 160 1747 1755 O
with 161 165 1756 1760 O
tenofovir 166 175 1761 1770 B-treatment
alafenamide 176 187 1771 1782 I-treatment
/ 187 188 1782 1783 O
emtricitabine 188 201 1783 1796 O

MAINTENANCE 0 11 1797 1808 B-treatment
THERAPY 12 19 1809 1816 I-treatment

MRD 0 3 1817 1820 B-chronic_disease
results 4 11 1821 1828 O
will 12 16 1829 1833 O
be 17 19 1834 1836 O
reported 20 28 1837 1845 O
to 29 31 1846 1848 O
the 32 35 1849 1852 O
submitting 36 46 1853 1863 O
institution 47 58 1864 1875 O

Mature 0 6 1876 1882 O
B 7 8 1883 1884 B-cancer
ALL 9 12 1885 1888 I-cancer
( 13 14 1889 1890 I-cancer
Burkitt's 14 23 1890 1899 I-cancer
- 23 24 1899 1900 I-cancer
like 24 28 1900 1904 I-cancer
leukemia 29 37 1905 1913 I-cancer
) 37 38 1913 1914 I-cancer

Men 0 3 1915 1918 B-gender
who 4 7 1919 1922 O
have 8 12 1923 1927 O
a 13 14 1928 1929 O
female 15 21 1930 1936 B-gender
partner 22 29 1937 1944 O
of 30 32 1945 1947 O
childbearing 33 45 1948 1960 O
potential 46 55 1961 1970 O
must 56 60 1971 1975 O
be 61 63 1976 1978 O
willing 64 71 1979 1986 B-contraception_consent
to 72 74 1987 1989 I-contraception_consent
use 75 78 1990 1993 I-contraception_consent
2 79 80 1994 1995 I-contraception_consent
highly 81 87 1996 2002 I-contraception_consent
effective 88 97 2003 2012 I-contraception_consent
forms 98 103 2013 2018 I-contraception_consent
of 104 106 2019 2021 I-contraception_consent
contraception 107 120 2022 2035 I-contraception_consent
throughout 121 131 2036 2046 O
protocol 132 140 2047 2055 O
therapy 141 148 2056 2063 B-treatment
and 149 152 2064 2067 O
for 153 156 2068 2071 O
at 157 159 2072 2074 O
least 160 165 2075 2080 O
an 166 168 2081 2083 O
additional 169 179 2084 2094 O
3 180 181 2095 2096 B-lower_bound
months 182 188 2097 2103 I-lower_bound
after 189 194 2104 2109 O
the 195 198 2110 2113 O
last 199 203 2114 2118 O
dose 204 208 2119 2123 O
of 209 211 2124 2126 O
protocol 212 220 2127 2135 B-treatment
- 220 221 2135 2136 I-treatment
specified 221 230 2136 2145 I-treatment
therapy 231 238 2146 2153 I-treatment

New 0 3 2154 2157 O
diagnosis 4 13 2158 2167 O
of 14 16 2168 2170 O
B 17 18 2171 2172 B-cancer
lineage 19 26 2173 2180 I-cancer
ALL 27 30 2181 2184 I-cancer
must 31 35 2185 2189 O
be 36 38 2190 2192 O
made 39 43 2193 2197 O
upon 44 48 2198 2202 O
bone 49 53 2203 2207 O
marrow 54 60 2208 2214 O
or 61 63 2215 2217 O
peripheral 64 74 2218 2228 O
blood 75 80 2229 2234 O
immunophenotyping 81 98 2235 2252 O
; 98 99 2252 2253 O
cases 100 105 2254 2259 O
with 106 110 2260 2264 O
myeloid 111 118 2265 2272 O
antigen 119 126 2273 2280 O
expression 127 137 2281 2291 O
, 137 138 2291 2292 O
but 139 142 2293 2296 O
unequivocal 143 154 2297 2308 O
lymphoid 155 163 2309 2317 O
immunophenotype 164 179 2318 2333 O

No 0 2 2334 2336 O
history 3 10 2337 2344 O
of 11 13 2345 2347 O
acquired 14 22 2348 2356 B-chronic_disease
immune 23 29 2357 2363 I-chronic_disease
deficiency 30 40 2364 2374 I-chronic_disease
syndrome 41 49 2375 2383 I-chronic_disease
( 50 51 2384 2385 I-chronic_disease
AIDS)-related 51 64 2385 2398 I-chronic_disease
complications 65 78 2399 2412 O
other 79 84 2413 2418 O
than 85 89 2419 2423 O
a 90 91 2424 2425 O
history 92 99 2426 2433 O
of 100 102 2434 2436 O
low 103 106 2437 2440 B-clinical_variable
CD4 107 110 2441 2444 I-clinical_variable
+ 110 111 2444 2445 I-clinical_variable
T 112 113 2446 2447 I-clinical_variable
- 113 114 2447 2448 I-clinical_variable
cell 114 118 2448 2452 I-clinical_variable
count 119 124 2453 2458 I-clinical_variable
( 125 126 2459 2460 O
< 126 127 2460 2461 O
200 128 131 2462 2465 B-upper_bound
/ 131 132 2465 2466 I-upper_bound
mm^3 132 136 2466 2470 I-upper_bound
) 136 137 2470 2471 O
prior 138 143 2472 2477 B-treatment
to 144 146 2478 2480 I-treatment
initiation 147 157 2481 2491 I-treatment
of 158 160 2492 2494 I-treatment
combination 161 172 2495 2506 I-treatment
antiretroviral 173 187 2507 2521 I-treatment
therapy 188 195 2522 2529 I-treatment
; 195 196 2529 2530 O
on 197 199 2531 2533 O
study 200 205 2534 2539 O
CD4 206 209 2540 2543 O
+ 209 210 2543 2544 O
T 211 212 2545 2546 O
- 212 213 2546 2547 O
cell 213 217 2547 2551 O
count 218 223 2552 2557 O
may 224 227 2558 2561 O
not 228 231 2562 2565 O
be 232 234 2566 2568 O
informative 235 246 2569 2580 O
due 247 250 2581 2584 O
to 251 253 2585 2587 O
leukemia 254 262 2588 2596 B-cancer
and 263 266 2597 2600 O
should 267 273 2601 2607 O
not 274 277 2608 2611 O
be 278 280 2612 2614 O
used 281 285 2615 2619 O
as 286 288 2620 2622 O
an 289 291 2623 2625 O
exclusion 292 301 2626 2635 O
criterion 302 311 2636 2645 O
if 312 314 2646 2648 O
low 315 318 2649 2652 O

POST 0 4 2653 2657 B-treatment
- 4 5 2657 2658 I-treatment
INDUCTION 5 14 2658 2667 I-treatment
THERAPY 15 22 2668 2675 I-treatment

Patient 0 7 2676 2683 O
must 8 12 2684 2688 O
be 13 15 2689 2691 O
CNS 16 19 2692 2695 O
( 20 21 2696 2697 O
cerebrospinal 21 34 2697 2710 O
fluid 35 40 2711 2716 O
[ 41 42 2717 2718 O
CSF 42 45 2718 2721 O
] 45 46 2721 2722 O
) 46 47 2722 2723 O
negative 48 56 2724 2732 O
for 57 60 2733 2736 O
leukemia 61 69 2737 2745 B-cancer

Patient 0 7 2746 2753 O
must 8 12 2754 2758 O
be 13 15 2759 2761 O
healthy 16 23 2762 2769 O
on 24 26 2770 2772 O
the 27 30 2773 2776 O
basis 31 36 2777 2782 O
of 37 39 2783 2785 O
HIV 40 43 2786 2789 B-chronic_disease
disease 44 51 2790 2797 O
with 52 56 2798 2802 O
high 57 61 2803 2807 O
likelihood 62 72 2808 2818 O
of 73 75 2819 2821 O
near 76 80 2822 2826 O
normal 81 87 2827 2833 O
life 88 92 2834 2838 O
span 93 97 2839 2843 O
were 98 102 2844 2848 O
it 103 105 2849 2851 O
not 106 109 2852 2855 O
for 110 113 2856 2859 O
the 114 117 2860 2863 O
leukemia 118 126 2864 2872 B-cancer

Patient 0 7 2873 2880 O
must 8 12 2881 2885 O
be 13 15 2886 2888 O
on 16 18 2889 2891 O
combination 19 30 2892 2903 O
antiretroviral 31 45 2904 2918 B-treatment
therapy 46 53 2919 2926 I-treatment
with 54 58 2927 2931 O
minimal 59 66 2932 2939 O
pharmacokinetic 67 82 2940 2955 O
interactions 83 95 2956 2968 O
with 96 100 2969 2973 O
study 101 106 2974 2979 O
therapy 107 114 2980 2987 O
and 115 118 2988 2991 O
minimal 119 126 2992 2999 O
overlapping 127 138 3000 3011 O
clinical 139 147 3012 3020 O
toxicity 148 156 3021 3029 O
with 157 161 3030 3034 O
protocol 162 170 3035 3043 B-treatment
therapy 171 178 3044 3051 I-treatment

Patient 0 7 3052 3059 O
must 8 12 3060 3064 O
have 13 17 3065 3069 O
a 18 19 3070 3071 O
normal 20 26 3072 3078 O
cardiac 27 34 3079 3086 B-clinical_variable
ejection 35 43 3087 3095 I-clinical_variable
fraction 44 52 3096 3104 I-clinical_variable
by 53 55 3105 3107 O
pretreatment 56 68 3108 3120 O
multigated 69 79 3121 3131 B-treatment
acquisition 80 91 3132 3143 I-treatment
scan 92 96 3144 3148 I-treatment
( 97 98 3149 3150 I-treatment
MUGA 98 102 3150 3154 I-treatment
) 102 103 3154 3155 I-treatment
or 104 106 3156 3158 O
echocardiogram 107 121 3159 3173 B-treatment
within 122 128 3174 3180 O
4 129 130 3181 3182 B-upper_bound
weeks 131 136 3183 3188 I-upper_bound
prior 137 142 3189 3194 I-upper_bound
to 143 145 3195 3197 O
registration 146 158 3198 3210 O
( 159 160 3211 3212 O
resting 160 167 3212 3219 B-clinical_variable
ejection 168 176 3220 3228 I-clinical_variable
fraction 177 185 3229 3237 I-clinical_variable
> 186 187 3238 3239 O
= 187 188 3239 3240 O
40 189 191 3241 3243 B-lower_bound
% 191 192 3243 3244 I-lower_bound
or 193 195 3245 3247 O
> 196 197 3248 3249 O
= 197 198 3249 3250 O
5 199 200 3251 3252 B-lower_bound
% 200 201 3252 3253 I-lower_bound
increase 202 210 3254 3262 O
with 211 215 3263 3267 O
exercise 216 224 3268 3276 O
) 224 225 3276 3277 O
, 225 226 3277 3278 O
shortening 227 237 3279 3289 B-clinical_variable
fraction 238 246 3290 3298 I-clinical_variable
by 247 249 3299 3301 O
echocardiogram 250 264 3302 3316 O
> 265 266 3317 3318 O
= 266 267 3318 3319 O
24 268 270 3320 3322 B-lower_bound
% 270 271 3322 3323 I-lower_bound
, 271 272 3323 3324 O
or 273 275 3325 3327 O
to 276 278 3328 3330 O
within 279 285 3331 3337 O
the 286 289 3338 3341 O
normal 290 296 3342 3348 O
range 297 302 3349 3354 O
of 303 305 3355 3357 O
values 306 312 3358 3364 O
for 313 316 3365 3368 O
the 317 320 3369 3372 O
institution 321 332 3373 3384 O

Patient 0 7 3385 3392 O
must 8 12 3393 3397 O
have 13 17 3398 3402 O
no 18 20 3403 3405 O
history 21 28 3406 3413 O
of 29 31 3414 3416 O
recent 32 38 3417 3423 O
myocardial 39 49 3424 3434 B-chronic_disease
infarction 50 60 3435 3445 I-chronic_disease
( 61 62 3446 3447 O
within 62 68 3447 3453 O
three 69 74 3454 3459 B-upper_bound
months 75 81 3460 3466 I-upper_bound
) 81 82 3466 3467 O
, 82 83 3467 3468 O
uncontrolled 84 96 3469 3481 O
congestive 97 107 3482 3492 B-chronic_disease
heart 108 113 3493 3498 I-chronic_disease
failure 114 121 3499 3506 I-chronic_disease
, 121 122 3506 3507 O
or 123 125 3508 3510 O
uncontrolled 126 138 3511 3523 O
cardiac 139 146 3524 3531 B-chronic_disease
arrhythmia 147 157 3532 3542 I-chronic_disease

Patient 0 7 3543 3550 O
must 8 12 3551 3555 O
have 13 17 3556 3560 O
serum 18 23 3561 3566 B-clinical_variable
HIV 24 27 3567 3570 I-clinical_variable
viral 28 33 3571 3576 I-clinical_variable
load 34 38 3577 3581 I-clinical_variable
of 39 41 3582 3584 O
< 42 43 3585 3586 O
200 44 47 3587 3590 B-upper_bound
copies 48 54 3591 3597 I-upper_bound
/ 54 55 3597 3598 I-upper_bound
mm^3 55 59 3598 3602 I-upper_bound

Patient 0 7 3603 3610 O
must 8 12 3611 3615 O
not 13 16 3616 3619 O
be 17 19 3620 3622 O
receiving 20 29 3623 3632 O
protease 30 38 3633 3641 B-treatment
inhibitors 39 49 3642 3652 I-treatment
or 50 52 3653 3655 O
once 53 57 3656 3660 O
daily 58 63 3661 3666 O
formulations 64 76 3667 3679 O
containing 77 87 3680 3690 O
cobicistat 88 98 3691 3701 B-treatment
, 98 99 3701 3702 O
stavudine 100 109 3703 3712 B-treatment
, 109 110 3712 3713 O
or 111 113 3714 3716 O
on 114 116 3717 3719 O
regimens 117 125 3720 3728 B-treatment
containing 126 136 3729 3739 O
stavudine 137 146 3740 3749 O
or 147 149 3750 3752 O
zidovudine 150 160 3753 3763 O

Patient 0 7 3764 3771 O
must 8 12 3772 3776 O
not 13 16 3777 3780 O
have 17 21 3781 3785 O
a 22 23 3786 3787 O
concurrent 24 34 3788 3798 O
active 35 41 3799 3805 O
malignancy 42 52 3806 3816 B-cancer
for 53 56 3817 3820 O
which 57 62 3821 3826 O
they 63 67 3827 3831 O
are 68 71 3832 3835 O
receiving 72 81 3836 3845 O
treatment 82 91 3846 3855 B-treatment

Patient 0 7 3856 3863 O
must 8 12 3864 3868 O
not 13 16 3869 3872 O
have 17 21 3873 3877 O
a 22 23 3878 3879 O
history 24 31 3880 3887 O
or 32 34 3888 3890 O
presence 35 43 3891 3899 O
of 44 46 3900 3902 O
clinically 47 57 3903 3913 O
relevant 58 66 3914 3922 O
central 67 74 3923 3930 O
nervous 75 82 3931 3938 O
system 83 89 3939 3945 O
( 90 91 3946 3947 O
CNS 91 94 3947 3950 O
) 94 95 3950 3951 O
pathology 96 105 3952 3961 O
such 106 110 3962 3966 O
as 111 113 3967 3969 O
epilepsy 114 122 3970 3978 B-chronic_disease
, 122 123 3978 3979 O
seizure 124 131 3980 3987 B-chronic_disease
, 131 132 3987 3988 O
paresis 133 140 3989 3996 B-chronic_disease
, 140 141 3996 3997 O
aphasia 142 149 3998 4005 B-chronic_disease
, 149 150 4005 4006 O
stroke 151 157 4007 4013 B-chronic_disease
, 157 158 4013 4014 O
severe 159 165 4015 4021 O
brain 166 171 4022 4027 B-chronic_disease
injuries 172 180 4028 4036 I-chronic_disease
, 180 181 4036 4037 O
dementia 182 190 4038 4046 B-chronic_disease
; 190 191 4046 4047 O
Parkinson 192 201 4048 4057 B-chronic_disease
's 201 203 4057 4059 I-chronic_disease
disease 204 211 4060 4067 I-chronic_disease
, 211 212 4067 4068 O
cerebellar 213 223 4069 4079 B-chronic_disease
disease 224 231 4080 4087 I-chronic_disease
, 231 232 4087 4088 O
organic 233 240 4089 4096 B-chronic_disease
brain 241 246 4097 4102 I-chronic_disease
syndrome 247 255 4103 4111 I-chronic_disease
, 255 256 4111 4112 O
psychosis 257 266 4113 4122 B-chronic_disease
, 266 267 4122 4123 O
or 268 270 4124 4126 O
other 271 276 4127 4132 O
significant 277 288 4133 4144 O
CNS 289 292 4145 4148 B-chronic_disease
abnormalities 293 306 4149 4162 I-chronic_disease

Patient 0 7 4163 4170 O
must 8 12 4171 4175 O
not 13 16 4176 4179 O
have 17 21 4180 4184 O
an 22 24 4185 4187 O
active 25 31 4188 4194 O
uncontrolled 32 44 4195 4207 B-chronic_disease
infection 45 54 4208 4217 I-chronic_disease

Patient 0 7 4218 4225 O
must 8 12 4226 4230 O
not 13 16 4231 4234 O
have 17 21 4235 4239 O
an 22 24 4240 4242 O
antecedent 25 35 4243 4253 B-chronic_disease
hematologic 36 47 4254 4265 I-chronic_disease
disorder 48 56 4266 4274 I-chronic_disease

Patient 0 7 4275 4282 O
must 8 12 4283 4287 O
not 13 16 4288 4291 O
have 17 21 4292 4296 O
intercurrent 22 34 4297 4309 B-chronic_disease
organ 35 40 4310 4315 I-chronic_disease
damage 41 47 4316 4322 I-chronic_disease
or 48 50 4323 4325 O
medical 51 58 4326 4333 O
problems 59 67 4334 4342 O
that 68 72 4343 4347 O
will 73 77 4348 4352 O
jeopardize 78 88 4353 4363 O
the 89 92 4364 4367 O
outcome 93 100 4368 4375 O
of 101 103 4376 4378 O
therapy 104 111 4379 4386 B-treatment
( 112 113 4387 4388 O
i.e. 113 117 4388 4392 O
, 117 118 4392 4393 O
psychiatric 119 130 4394 4405 B-chronic_disease
disorder 131 139 4406 4414 I-chronic_disease
, 139 140 4414 4415 O
drug 141 145 4416 4420 O
abuse 146 151 4421 4426 O
, 151 152 4426 4427 O
pregnancy 153 162 4428 4437 B-pregnancy
) 162 163 4437 4438 O

Patient 0 7 4439 4446 O
should 8 14 4447 4453 O
be 15 17 4454 4456 O
human 18 23 4457 4462 O
leukocyte 24 33 4463 4472 O
antigen 34 41 4473 4480 O
( 42 43 4481 4482 O
HLA 43 46 4482 4485 O
) 46 47 4485 4486 O
typed 48 53 4487 4492 O
( 54 55 4493 4494 O
A 55 56 4494 4495 O
, 56 57 4495 4496 O
B 58 59 4497 4498 O
, 59 60 4498 4499 O
C 61 62 4500 4501 O
, 62 63 4501 4502 O
DR 64 66 4503 4505 O
and 67 70 4506 4509 O
DQ 71 73 4510 4512 O
) 73 74 4512 4513 O
during 75 81 4514 4520 O
induction 82 91 4521 4530 B-treatment
therapy 92 99 4531 4538 I-treatment
phase 100 105 4539 4544 O
or 106 108 4545 4547 O
a 109 110 4548 4549 O
written 111 118 4550 4557 O
explanation 119 130 4558 4569 O
for 131 134 4570 4573 O
not 135 138 4574 4577 O
undergoing 139 149 4578 4588 O
HLA 150 153 4589 4592 O
typing 154 160 4593 4599 O
on 161 163 4600 4602 O
the 164 167 4603 4606 O
flow 168 172 4607 4611 O
sheet 173 178 4612 4617 O

Patients 0 8 4618 4626 O
must 9 13 4627 4631 O
be 14 16 4632 4634 O
considered 17 27 4635 4645 O
reliable 28 36 4646 4654 O
enough 37 43 4655 4661 O
to 44 46 4662 4664 O
comply 47 53 4665 4671 O
with 54 58 4672 4676 O
the 59 62 4677 4680 O
medication 63 73 4681 4691 B-treatment
regimen 74 81 4692 4699 O
and 82 85 4700 4703 O
follow 86 92 4704 4710 O
- 92 93 4710 4711 O
up 93 95 4711 4713 O
, 95 96 4713 4714 O
and 97 100 4715 4718 O
have 101 105 4719 4723 O
social 106 112 4724 4730 O
support 113 120 4731 4738 O
necessary 121 130 4739 4748 O
to 131 133 4749 4751 O
allow 134 139 4752 4757 O
this 140 144 4758 4762 O
compliance 145 155 4763 4773 O

Patients 0 8 4774 4782 O
must 9 13 4783 4787 O
have 14 18 4788 4792 O
achieved 19 27 4793 4801 O
a 28 29 4802 4803 O
CR 30 32 4804 4806 B-clinical_variable
or 33 35 4807 4809 O
CRi 36 39 4810 4813 B-clinical_variable

Patients 0 8 4814 4822 O
must 9 13 4823 4827 O
have 14 18 4828 4832 O
an 19 21 4833 4835 O
ECOG 22 26 4836 4840 B-clinical_variable
performance 27 38 4841 4852 I-clinical_variable
status 39 45 4853 4859 I-clinical_variable
of 46 48 4860 4862 O
0 49 50 4863 4864 B-lower_bound
- 50 51 4864 4865 O
2 51 52 4865 4866 B-upper_bound

Patients 0 8 4867 4875 O
must 9 13 4876 4880 O
have 14 18 4881 4885 O
an 19 21 4886 4888 O
ECOG 22 26 4889 4893 B-clinical_variable
performance 27 38 4894 4905 I-clinical_variable
status 39 45 4906 4912 I-clinical_variable
of 46 48 4913 4915 O
0 49 50 4916 4917 B-lower_bound
- 50 51 4917 4918 O
3 51 52 4918 4919 B-upper_bound

Patients 0 8 4920 4928 O
must 9 13 4929 4933 O
have 14 18 4934 4938 O
maintained 19 29 4939 4949 O
peripheral 30 40 4950 4960 O
blood 41 46 4961 4966 O
evidence 47 55 4967 4975 O
of 56 58 4976 4978 O
a 59 60 4979 4980 O
remission 61 70 4981 4990 O
and 71 74 4991 4994 O
must 75 79 4995 4999 O
have 80 84 5000 5004 O
a 85 86 5005 5006 O
CR 87 89 5007 5009 O
or 90 92 5010 5012 O
CRi 93 96 5013 5016 O
, 96 97 5016 5017 O
confirmed 98 107 5018 5027 O
on 108 110 5028 5030 O
restaging 111 120 5031 5040 O
BM 121 123 5041 5043 O
aspirate 124 132 5044 5052 O
and 133 136 5053 5056 O
biopsy 137 143 5057 5063 B-treatment

Patients 0 8 5064 5072 O
must 9 13 5073 5077 O
have 14 18 5078 5082 O
maintained 19 29 5083 5093 O
peripheral 30 40 5094 5104 O
blood 41 46 5105 5110 O
evidence 47 55 5111 5119 O
of 56 58 5120 5122 O
a 59 60 5123 5124 O
remission 61 70 5125 5134 O
and 71 74 5135 5138 O
must 75 79 5139 5143 O
have 80 84 5144 5148 O
a 85 86 5149 5150 O
CR 87 89 5151 5153 O
or 90 92 5154 5156 O
CRi 93 96 5157 5160 O
, 96 97 5160 5161 O
confirmed 98 107 5162 5171 O
on 108 110 5172 5174 O
restaging 111 120 5175 5184 O
bone 121 125 5185 5189 B-treatment
marrow 126 132 5190 5196 I-treatment
( 133 134 5197 5198 I-treatment
BM 134 136 5198 5200 I-treatment
) 136 137 5200 5201 I-treatment
aspirate 138 146 5202 5210 I-treatment
and 147 150 5211 5214 O
biopsy 151 157 5215 5221 B-treatment

Patients 0 8 5222 5230 O
must 9 13 5231 5235 O
have 14 18 5236 5240 O
resolved 19 27 5241 5249 O
any 28 31 5250 5253 O
serious 32 39 5254 5261 B-chronic_disease
infectious 40 50 5262 5272 I-chronic_disease
complications 51 64 5273 5286 O
related 65 72 5287 5294 O
to 73 75 5295 5297 O
therapy 76 83 5298 5305 B-treatment

Patients 0 8 5306 5314 O
should 9 15 5315 5321 O
meet 16 20 5322 5326 O
the 21 24 5327 5330 O
eligibility 25 36 5331 5342 O
criteria 37 45 5343 5351 O
for 46 49 5352 5355 O
RANDOMIZATION 50 63 5356 5369 O
TO 64 66 5370 5372 O
BLINATUMOMAB 67 79 5373 5385 B-treatment
OR 80 82 5386 5388 O
NO 83 85 5389 5391 O
BLINATUMOMAB 86 98 5392 5404 O
- 98 99 5404 5405 O
STEP 99 103 5405 5409 O
3 104 105 5410 5411 O

Patients 0 8 5412 5420 O
with 9 13 5421 5425 O
known 14 19 5426 5431 O
human 20 25 5432 5437 B-chronic_disease
immunodeficiency 26 42 5438 5454 I-chronic_disease
virus 43 48 5455 5460 I-chronic_disease
( 49 50 5461 5462 I-chronic_disease
HIV 50 53 5462 5465 I-chronic_disease
) 53 54 5465 5466 I-chronic_disease
infection 55 64 5467 5476 O

RANDOMIZATION 0 13 5477 5490 O
TO 14 16 5491 5493 O
BLINATUMOMAB 17 29 5494 5506 B-treatment
OR 30 32 5507 5509 O
NO 33 35 5510 5512 O
BLINATUMOMAB 36 48 5513 5525 O
- 48 49 5525 5526 O
STEP 49 53 5526 5530 O
3 54 55 5531 5532 O

Serum 0 5 5533 5538 B-clinical_variable
creatinine 6 16 5539 5549 I-clinical_variable
< 17 18 5550 5551 O
1.5 19 22 5552 5555 B-upper_bound
x 23 24 5556 5557 I-upper_bound
ULN 25 28 5558 5561 I-upper_bound
; 28 29 5561 5562 O
the 30 33 5563 5566 O
values 34 40 5567 5573 O
must 41 45 5574 5578 O
be 46 48 5579 5581 O
obtained 49 57 5582 5590 O
within 58 64 5591 5597 O
48 65 67 5598 5600 B-upper_bound
hours 68 73 5601 5606 I-upper_bound
prior 74 79 5607 5612 I-upper_bound
to 80 82 5613 5615 O
randomization 83 96 5616 5629 O

Serum 0 5 5630 5635 B-clinical_variable
creatinine 6 16 5636 5646 I-clinical_variable
< 17 18 5647 5648 O
2 19 20 5649 5650 B-upper_bound
mg 21 23 5651 5653 I-upper_bound
/ 23 24 5653 5654 I-upper_bound
dl 24 26 5654 5656 I-upper_bound
( 27 28 5657 5658 O
obtained 28 36 5658 5666 O
= 37 38 5667 5668 O
< 38 39 5668 5669 O
48 40 42 5670 5672 B-upper_bound
hours 43 48 5673 5678 I-upper_bound
prior 49 54 5679 5684 I-upper_bound
to 55 57 5685 5687 O
registration 58 70 5688 5700 O
) 70 71 5700 5701 O

Serum 0 5 5702 5707 B-clinical_variable
creatinine 6 16 5708 5718 I-clinical_variable
= 17 18 5719 5720 O
< 18 19 5720 5721 O
2.0 20 23 5722 5725 B-upper_bound
mg 24 26 5726 5728 I-upper_bound
/ 26 27 5728 5729 I-upper_bound
dl 27 29 5729 5731 I-upper_bound
( 30 31 5732 5733 O
obtained 31 39 5733 5741 B-clinical_variable
= 40 41 5742 5743 O
< 41 42 5743 5744 O
48 43 45 5745 5747 B-upper_bound
hours 46 51 5748 5753 I-upper_bound
prior 52 57 5754 5759 I-upper_bound
to 58 60 5760 5762 O
registration 61 73 5763 5775 O
) 73 74 5775 5776 O

Serum 0 5 5777 5782 O
direct 6 12 5783 5789 B-clinical_variable
bilirubin 13 22 5790 5799 I-clinical_variable
< 23 24 5800 5801 O
2 25 26 5802 5803 B-upper_bound
mg 27 29 5804 5806 I-upper_bound
/ 29 30 5806 5807 I-upper_bound
dL 30 32 5807 5809 I-upper_bound
or 33 35 5810 5812 O
serum 36 41 5813 5818 O
total 42 47 5819 5824 B-clinical_variable
bilirubin 48 57 5825 5834 I-clinical_variable
= 58 59 5835 5836 O
< 59 60 5836 5837 O
3 61 62 5838 5839 B-upper_bound
( 63 64 5840 5841 O
obtained 64 72 5841 5849 O
= 73 74 5850 5851 O
< 74 75 5851 5852 O
48 76 78 5853 5855 B-upper_bound
hours 79 84 5856 5861 I-upper_bound
prior 85 90 5862 5867 I-upper_bound
to 91 93 5868 5870 O
registration 94 106 5871 5883 O
) 106 107 5883 5884 O

Serum 0 5 5885 5890 B-clinical_variable
direct 6 12 5891 5897 I-clinical_variable
bilirubin 13 22 5898 5907 I-clinical_variable
< 23 24 5908 5909 O
2 25 26 5910 5911 B-upper_bound
mg 27 29 5912 5914 I-upper_bound
/ 29 30 5914 5915 I-upper_bound
dl 30 32 5915 5917 I-upper_bound
or 33 35 5918 5920 O
serum 36 41 5921 5926 B-clinical_variable
total 42 47 5927 5932 I-clinical_variable
bilirubin 48 57 5933 5942 I-clinical_variable
= 58 59 5943 5944 O
< 59 60 5944 5945 O
3 61 62 5946 5947 B-upper_bound
( 63 64 5948 5949 O
obtained 64 72 5949 5957 O
= 73 74 5958 5959 O
< 74 75 5959 5960 O
48 76 78 5961 5963 B-upper_bound
hours 79 84 5964 5969 I-upper_bound
prior 85 90 5970 5975 I-upper_bound
to 91 93 5976 5978 O
registration 94 106 5979 5991 O
) 106 107 5991 5992 O

Women 0 5 5993 5998 B-gender
must 6 10 5999 6003 O
not 11 14 6004 6007 B-pregnancy
be 15 17 6008 6010 I-pregnancy
pregnant 18 26 6011 6019 I-pregnancy
or 27 29 6020 6022 O
breast 30 36 6023 6029 O
- 36 37 6029 6030 O
feeding 37 44 6030 6037 O
and 45 48 6038 6041 O
must 49 53 6042 6046 O
not 54 57 6047 6050 B-pregnancy
become 58 64 6051 6057 I-pregnancy
pregnant 65 73 6058 6066 I-pregnancy
or 74 76 6067 6069 O
breastfeed 77 87 6070 6080 O
during 88 94 6081 6087 O
protocol 95 103 6088 6096 B-treatment
therapy 104 111 6097 6104 I-treatment
and 112 115 6105 6108 O
for 116 119 6109 6112 O
at 120 122 6113 6115 O
least 123 128 6116 6121 O
3 129 130 6122 6123 B-lower_bound
months 131 137 6124 6130 I-lower_bound
after 138 143 6131 6136 I-lower_bound
protocol 144 152 6137 6145 O
therapy 153 160 6146 6153 O

a 0 1 6154 6155 O
female 2 8 6156 6162 B-gender
of 9 11 6163 6165 O
childbearing 12 24 6166 6178 O
potential 25 34 6179 6188 O
is 35 37 6189 6191 O
any 38 41 6192 6195 O
woman 42 47 6196 6201 B-gender
, 47 48 6201 6202 O
regardless 49 59 6203 6213 O
of 60 62 6214 6216 O
sexual 63 69 6217 6223 O
orientation 70 81 6224 6235 O
or 82 84 6236 6238 O
whether 85 92 6239 6246 O
they 93 97 6247 6251 O
have 98 102 6252 6256 O
undergone 103 112 6257 6266 O
tubal 113 118 6267 6272 B-treatment
ligation 119 127 6273 6281 I-treatment
, 127 128 6281 6282 O
who 129 132 6283 6286 O
meets 133 138 6287 6292 O
the 139 142 6293 6296 O
following 143 152 6297 6306 O
criteria 153 161 6307 6315 O
: 161 162 6315 6316 O
has 163 166 6317 6320 O
not 167 170 6321 6324 O
undergone 171 180 6325 6334 O
a 181 182 6335 6336 O
hysterectomy 183 195 6337 6349 B-treatment
or 196 198 6350 6352 O
bilateral 199 208 6353 6362 B-treatment
oophorectomy 209 221 6363 6375 I-treatment
; 221 222 6375 6376 O
or 223 225 6377 6379 O
has 226 229 6380 6383 O
not 230 233 6384 6387 O
been 234 238 6388 6392 O
naturally 239 248 6393 6402 O
postmenopausal 249 263 6403 6417 O
for 264 267 6418 6421 O
at 268 270 6422 6424 O
least 271 276 6425 6430 O
24 277 279 6431 6433 B-lower_bound
consecutive 280 291 6434 6445 I-lower_bound
months 292 298 6446 6452 I-lower_bound
( 299 300 6453 6454 O
i.e. 300 304 6454 6458 O
, 304 305 6458 6459 O
has 306 309 6460 6463 O
had 310 313 6464 6467 O
menses 314 320 6468 6474 O
at 321 323 6475 6477 O
any 324 327 6478 6481 O
time 328 332 6482 6486 O
in 333 335 6487 6489 O
the 336 339 6490 6493 O
preceding 340 349 6494 6503 B-upper_bound
24 350 352 6504 6506 I-upper_bound
consecutive 353 364 6507 6518 I-upper_bound
months 365 371 6519 6525 I-upper_bound
) 371 372 6525 6526 O

all 0 3 6527 6530 O
females 4 11 6531 6538 B-gender
of 12 14 6539 6541 O
childbearing 15 27 6542 6554 O
potential 28 37 6555 6564 O
must 38 42 6565 6569 O
have 43 47 6570 6574 O
a 48 49 6575 6576 O
blood 50 55 6577 6582 O
test 56 60 6583 6587 O
or 61 63 6588 6590 O
urine 64 69 6591 6596 O
study 70 75 6597 6602 O
within 76 82 6603 6609 O
2 83 84 6610 6611 B-upper_bound
weeks 85 90 6612 6617 I-upper_bound
prior 91 96 6618 6623 I-upper_bound
to 97 99 6624 6626 O
registration 100 112 6627 6639 O
to 113 115 6640 6642 O
rule 116 120 6643 6647 O
out 121 124 6648 6651 O
pregnancy 125 134 6652 6661 B-pregnancy

men 0 3 6662 6665 B-gender
who 4 7 6666 6669 O
have 8 12 6670 6674 O
a 13 14 6675 6676 O
pregnant 15 23 6677 6685 B-pregnancy
partner 24 31 6686 6693 O
must 32 36 6694 6698 O
be 37 39 6699 6701 O
willing 40 47 6702 6709 B-contraception_consent
to 48 50 6710 6712 I-contraception_consent
use 51 54 6713 6716 I-contraception_consent
a 55 56 6717 6718 I-contraception_consent
condom 57 63 6719 6725 I-contraception_consent
during 64 70 6726 6732 O
sexual 71 77 6733 6739 O
activity 78 86 6740 6748 O
throughout 87 97 6749 6759 O
protocol 98 106 6760 6768 O
therapy 107 114 6769 6776 B-treatment
and 115 118 6777 6780 O
for 119 122 6781 6784 O
3 123 124 6785 6786 B-upper_bound
months 125 131 6787 6793 I-upper_bound
after 132 137 6794 6799 I-upper_bound
the 138 141 6800 6803 O
last 142 146 6804 6808 O
dose 147 151 6809 6813 O
of 152 154 6814 6816 O
protocol 155 163 6817 6825 O
- 163 164 6825 6826 O
specified 164 173 6826 6835 O
therapy 174 181 6836 6843 O

pre 0 3 6844 6847 O
- 3 4 6847 6848 O
study 4 9 6848 6853 O
bone 10 14 6854 6858 B-treatment
marrow 15 21 6859 6865 I-treatment
biopsy 22 28 6866 6872 I-treatment
and 29 32 6873 6876 I-treatment
aspirate 33 41 6877 6885 I-treatment
must 42 46 6886 6890 O
be 47 49 6891 6893 O
completed 50 59 6894 6903 O
= 60 61 6904 6905 O
< 61 62 6905 6906 O
1 63 64 6907 6908 B-upper_bound
week 65 69 6909 6913 I-upper_bound
prior 70 75 6914 6919 I-upper_bound
to 76 78 6920 6922 O
registration 79 91 6923 6935 O

woman 0 5 6936 6941 B-gender
of 6 8 6942 6944 O
childbearing 9 21 6945 6957 O
potential 22 31 6958 6967 O
must 32 36 6968 6972 O
abstain 37 44 6973 6980 B-contraception_consent
from 45 49 6981 6985 I-contraception_consent
sexual 50 56 6986 6992 I-contraception_consent
activity 57 65 6993 7001 I-contraception_consent
or 66 68 7002 7004 O
be 69 71 7005 7007 O
willing 72 79 7008 7015 B-contraception_consent
to 80 82 7016 7018 I-contraception_consent
use 83 86 7019 7022 I-contraception_consent
2 87 88 7023 7024 I-contraception_consent
highly 89 95 7025 7031 I-contraception_consent
effective 96 105 7032 7041 I-contraception_consent
forms 106 111 7042 7047 I-contraception_consent
of 112 114 7048 7050 I-contraception_consent
contraception 115 128 7051 7064 I-contraception_consent
throughout 129 139 7065 7075 O
protocol 140 148 7076 7084 O
therapy 149 156 7085 7092 B-treatment
and 157 160 7093 7096 O
for 161 164 7097 7100 O
at 165 167 7101 7103 O
least 168 173 7104 7109 O
an 174 176 7110 7112 O
additional 177 187 7113 7123 O
3 188 189 7124 7125 B-lower_bound
months 190 196 7126 7132 I-lower_bound
after 197 202 7133 7138 I-lower_bound
the 203 206 7139 7142 O
last 207 211 7143 7147 O
dose 212 216 7148 7152 O
of 217 219 7153 7155 O
protocol 220 228 7156 7164 B-treatment
- 228 229 7164 7165 I-treatment
specified 229 238 7165 7174 I-treatment
therapy 239 246 7175 7182 I-treatment

